Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-174612
Filing Date
2024-07-03
Accepted
2024-07-03 06:02:55
Documents
4
Period of Report
2024-07-03

Document Format Files

Seq Description Document Type Size
1 6-K d845350d6k.htm 6-K 9716
2 EX-99.1 d845350dex991.htm EX-99.1 12383
3 GRAPHIC g845350dsp4.jpg GRAPHIC 9391
4 GRAPHIC g845350dsp4a.jpg GRAPHIC 4870
  Complete submission text file 0001193125-24-174612.txt   43234
Mailing Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000
Business Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000 612 8315 7003
IMMUTEP Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 241098164
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)